<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368604">
  <stage>Registered</stage>
  <submitdate>17/09/2015</submitdate>
  <approvaldate>4/11/2015</approvaldate>
  <actrnumber>ACTRN12615001193561</actrnumber>
  <trial_identification>
    <studytitle>A pilot study of dose schedules for pamidronate infusions in the management of non-specific low back pain</studytitle>
    <scientifictitle>A pilot study comparing  two dose schedules(two 90 mg doses on consecutive days versus two 90mg doses 28 days apart) for the delivery of intravenous pamidronate in the management of chronic non-specific low back pain.</scientifictitle>
    <utrn>U1111-1170-4165 </utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>non-specific Low back Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Pamidronate infusion of 90mg.
Two doses given either on consecutive days or 28 days apart.
Each dose given over 4 hours in hospital ward.
Infusion monitored by study nurse or doctor.</interventions>
    <comparator>Comparison of dose schedules of pamidronate in non specific low back pain.

Comparison of two 90 mg doses given on consecutive days and 28 days apart. 

The dose given 28 days apart is the control dose.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of patients who show an improvement in Pain Scores measured on the Brief Pain Inventory (short form)
</outcome>
      <timepoint>six months post first infusion dose</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Global impression of change(Quality of life)
</outcome>
      <timepoint>six months post first infusion dose</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients referred to chronic pain clinic at Tauranga Hospital.
Chronic non specific low back pain of at least three months duration
Pain score greater than 4 on numerical rating scale</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Primary diagnosis of radicular or neuropathic pain
Vertebral compression fracture or cancer
Allergy to pamidronate
Significant other medical problems (renal, liver, cardiac, respiratory)
History of alcohol or drug abuse
Pending legal or compensation claim
Planned surgery or significant intervention in next six months
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>16/11/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Bay Of Plenty</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Tauranga Hospital. Bay Of Plenty DHB</primarysponsorname>
    <primarysponsoraddress>Tauranga Hospital
Cameron Road
Private Bag 12024
Tauranga 3143

</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>BOP Medical Research Trust</fundingname>
      <fundingaddress>BOP Medical Research Trust
PO Box 752
Tauranga 3140
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A randomized cohort pilot trial which will compare any significant statistical differences in either benefit or adverse effects on participants pain scores and quality of life when given a Pamidronate infusion(total dose 180mg) either on two consecutive days or 28 days apart to aid in the management of chronic non-specific low back pain.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Health and Disability ethics comittee. Northern B</ethicname>
      <ethicaddress>Ministry of Health
Ethics Department
Freyberg Building
Reception  Ground Floor
20 Aitken Street
Wellington 6011
.</ethicaddress>
      <ethicapprovaldate>11/08/2015</ethicapprovaldate>
      <hrec>15\MTB\130</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Saad Anis</name>
      <address>Chronic Pain Service
Tauranga Hospital
Private Bag 12024
Tauranga
3143</address>
      <phone>+64 7 557 5038</phone>
      <fax />
      <email>saad.anis@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Vicky Beveridge</name>
      <address>Chronic Pain Service
Tauranga Hospital
Private Bag 12024
Tauranga
3143</address>
      <phone>+64 7 557 5038</phone>
      <fax />
      <email>vicky.beveridge@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Saad Anis</name>
      <address>Chronic Pain Service
Tauranga Hospital
Private Bag 12024
Tauranga
3143</address>
      <phone>+64 7 557 5038</phone>
      <fax />
      <email>saad.anis@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>